Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Reumatología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Parallel Group, Placebo-controlled Multicenter Phase 3 Study to Evaluate Efficacy, Safety and Tolerability of Two Regimens of Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 1)
INTERVENTIONAL
Inicio: 2 de mar de 2023
ID: NCT05639114
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Therapy
INTERVENTIONAL
Inicio: 1 de oct de 2012
ID: NCT01710358
Terminado
Fase 2
ClinicalTrials.gov
A 5-year, Randomized, Double-blind, Placebo-controlled, Multi-center Study Assessing the Efficacy, Safety, and Tolerability of Intra-articular Regimens of LNA043 Versus Placebo in Patients With Symptomatic Knee Osteoarthritis
INTERVENTIONAL
Inicio: 31 de may de 2021
ID: NCT04864392
Terminado
Fase 2
ClinicalTrials.gov
A Phase II, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study To Evaluate the Safety and Efficacy of M2951 in Subjects With SLE
INTERVENTIONAL
Inicio: 4 de ene de 2017
ID: NCT02975336
Completado
Fase 4
ClinicalTrials.gov
A Multicenter, Randomized, Double-Period, Double - Blind Study to Determine the Optimal Protocol for Treatment Initiation With Methotrexate and Adalimumab Combination Therapy in Patients With Early Rheumatoid Arthritis (OPTIMA)
INTERVENTIONAL
Inicio: 1 de dic de 2006
ID: NCT00420927
Por invitación
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Dose-Blind, Phase 3 Long-Term Extension Study to Evaluate Continuous Safety and Efficacy of Litifilimab (BIIB059) in Adult Participants With Active Systemic Lupus Erythematosus
INTERVENTIONAL
Inicio: 10 de jun de 2022
ID: NCT05352919
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3, Multicenter, Open-label, Basket, LTE Study to Evaluate the Safety of Guselkumab in Pediatric Participants With Crohn's Disease, Ulcerative Colitis, or Juvenile Psoriatic Arthritis
INTERVENTIONAL
Inicio: 29 de oct de 2024
ID: NCT06663332
Completado
Fase 4
ClinicalTrials.gov
A Phase 3b/4 Randomized Double Blind Study Of 5 Mg Of Tofacitinib With And Without Methotrexate In Comparison To Adalimumab With Methotrexate In Subjects With Moderately To Severely Active Rheumatoid Arthritis
INTERVENTIONAL
Inicio: 1 de ago de 2014
ID: NCT02187055
Completado
Fase 2
ClinicalTrials.gov
Randomized, Parallel, Double-Blind, Placebo-Controlled Trial To Evaluate The Efficacy And Safety Of SBI-087 In Seropositive Subjects With Active Rheumatoid Arthritis On A Stable Background Of Methotrexate
INTERVENTIONAL
Inicio: 1 de dic de 2009
ID: NCT01008852
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Wk Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006, LymphoStat-B™), a Fully Human Monoclonal Anti-BLyS Antibody, in Subjects With Systemic Lupus Erythematosus (SLE)
INTERVENTIONAL
Inicio: 1 de may de 2007
ID: NCT00424476
Retirado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Active and Placebo-Controlled 16-Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Patients With Active Ankylosing Spondylitis
INTERVENTIONAL
Inicio: 1 de jul de 2014
ID: NCT01870284
Terminado
Fase 2
ClinicalTrials.gov
An Adaptive Phase II Study to Evaluate the Efficacy, Pharmacodynamics, Safety and Tolerability of GSK2586184 in Patients With Mild to Moderate Systemic Lupus Erythematosus
INTERVENTIONAL
Inicio: 1 de mar de 2013
ID: NCT01777256
Completado
Fase 3
ClinicalTrials.gov
A Phase III Multicentre, Double Blind, Placebo-controlled, Parallel Group 52-week Study to Assess the Efficacy and Safety of 2 Dose Regimens of Lyophilised CDP870 as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms and Preventing Structural Damage in Patients With Active Rheumatoid Arthritis Who Have an Incomplete Response to Methotrexate
INTERVENTIONAL
Inicio: 1 de feb de 2005
ID: NCT00152386
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O)
INTERVENTIONAL
Inicio: 1 de ene de 2011
ID: NCT01202760
Reclutando
Fase 2
ClinicalTrials.gov
Efectividad Del Plasma Rico en Plaquetas (PRP) Para la disminución Objetiva Del Dolor y la recuperación Funcional Del Miembro Inferior en Osteoartritis de Rodilla. Evaluación de Alternativas metodológicas
INTERVENTIONAL
Inicio: 1 de may de 2024
ID: NCT05825105
Completado
Fase 2
ClinicalTrials.gov
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
INTERVENTIONAL
Inicio: 1 de dic de 2011
ID: NCT01405196
Reclutando
Fase 2
ClinicalTrials.gov
Phase 2, Randomized, Double-Blind, Placebo-controlled, Parallel-Group, Multicenter Study to Evaluate the Safety and Efficacy of Tarperprumig in Adult Participants With Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (I TRANSCEND)
INTERVENTIONAL
Inicio: 26 de nov de 2025
ID: NCT07160608
Completado
Fase 2
ClinicalTrials.gov
A Phase 2 Randomized, Double-blind, Placebo-controlled, Dose-ranging, Efficacy and Safety Study of SAR441566 Plus Methotrexate in Adults With ModeratetoSevere Rheumatoid Arthritis
INTERVENTIONAL
Inicio: 7 de nov de 2023
ID: NCT06073093
Completado
Fase 3
ClinicalTrials.gov
A Multi-center, Uncontrolled Extension Study Evaluating Efficacy and Safety of SAR153191 in Patients With Active Rheumatoid Arthritis (RA)
INTERVENTIONAL
Inicio: 21 de jun de 2010
ID: NCT01146652
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Belimumab Plus Standard of Care Versus Placebo Plus Standard of Care in Adult Subjects With Active Lupus Nephritis
INTERVENTIONAL
Inicio: 12 de jul de 2012
ID: NCT01639339
Anterior
1
...
18
19
20
...
434
Siguiente
Filtros